US67018T1051 - Common Stock
NU SKIN ENTERPRISES INC - A
NYSE:NUS (11/20/2024, 8:04:00 PM)
After market: 7.49 0 (0%)7.49
-0.1 (-1.32%)
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. The company is headquartered in Provo, Utah and currently employs 3,700 full-time employees. The firm develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The firm has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. The company develops and distributes products in two categories, beauty products and wellness products. The firm operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Company’s Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.
NU SKIN ENTERPRISES INC - A
Attn: D. Matthew Dorny, 75 West Center St
Provo UTAH 84601
P: 18013456100
CEO: Ritch N. Wood
Employees: 3700
Website: https://www.nuskin.com/
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how The Honest Company (NASDAQ:HNST) and the rest of the personal care stocks fared in Q3.
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the personal care stocks, including e.l.f. (NYSE:ELF) and its peers.
Let’s dig into the relative performance of Nature's Sunshine (NASDAQ:NATR) and its peers as we unravel the now-completed Q3 personal care earnings season.
Personal care company Nu Skin (NYSE:NUS) fell short of the market’s revenue expectations in Q3 CY2024, with sales falling 13.8% year on year to $430.1 million. Next quarter’s revenue guidance of $427.5 million underwhelmed, coming in 6.2% below analysts’ estimates. Its non-GAAP profit of $0.17 per share was also 13.5% below analysts’ consensus estimates.
Here you can normally see the latest stock twits on NUS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: